BioSpace News Archive

Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market: Rise in prevalence of colorectal cancer to drive the market

Albany NY, United States: Gastroenteropancreatic neuroendocrine tumors are a large and differing group of uncommon and complex neoplasms.

April 4, 2022
·
5 min read
MEK Inhibitors Market Demand and Growth Opportunity – Global Industry Analysis [Forecast (2020-2030)]

The advances in the biotechnological fields have enabled researchers to identify the pathways which play a crucial role in the progression of cancer.

April 4, 2022
·
7 min read
Ovulation Inducing Drugs Market: Rise in Number of Patients Opting for IVF is Likely to Fuel the Growth Market

Albany NY, United States: Changing lifestyle, medicinal adverse effects, delayed pregnancy, and comorbidities are affecting natural reproduction among the human population.

April 4, 2022
·
5 min read
Biotech Bay

New Data for Genentech’s Ocrevus (ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis

Genentech, a member of the Roche Group, announced new Ocrevus® data that show its benefit on disease progression and cognitive outcomes in primary progressive multiple sclerosis and secondary progressive MS.

April 4, 2022
·
14 min read
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province

Ascletis Pharma Inc. announces that the first sale of its ritonavir tablets in Zhejiang Province has been completed.

April 4, 2022
·
4 min read
Business

Press Release: Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board

Sanofi launches its Diversity, Equity & Inclusion Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors.

April 4, 2022
·
5 min read
Business

Tessa Therapeutics Appoints Wilson W. Cheung as Chief Financial Officer

Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced the appointment of Wilson W. Cheung as its chief financial officer effective April 1, 2022.

April 4, 2022
·
5 min read
Drug Development

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Topline Results from the 24-Month Phase III BALANCE Clinical Trial of PRX-102 for the Treatment of Fabry Disease

Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases announced topline results from the BALANCE pivotal Phase III clinical trial evaluating pegunigalsidase alfa, 1 mg/kg, administered every two weeks, compared to agalsidase beta for the treatment of Fabry disease.

April 4, 2022
·
17 min read
Genetown

Apellis Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in complement, announced that the company will present at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 3:00 p.m. ET.

April 4, 2022
·
1 min read
Biotech Bay

Microba Life Sciences and Ginkgo Bioworks Announce Partnership to Discover Novel Live Biotherapeutics

Microba Life Sciences, a precision microbiome science company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced a partnership to identify single-strain, live bacteria product candidates against autoimmune diseases.

April 4, 2022
·
6 min read